{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:38:27Z","timestamp":1787841507059,"version":"build-2784847793"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Objective:<\/jats:title>\n                    <jats:p>Diabetic-range hyperglycemia has been reported for the first time in many patients during their hospitalization with coronavirus disease 2019 (COVID-19). This study was undertaken to determine the proportion of such patients who actually have new-onset diabetes mellitus rather than transient hyperglycemia during acute illness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This descriptive study included patients with diabetic-range hyperglycemia first detected at or during admission for COVID-19 but no prior history of diabetes. The study protocol involved patient identification, data recording from the case-notes, and telephonic follow-ups. Blood sugar levels done at least two weeks after discharge or the last dose of steroids, whichever was later, were recorded, and patients were categorized as diabetic, pre-diabetic, or non-diabetic accordingly<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Out of 86 patients, ten (11.6%) were found to have developed diabetes, and 13 (15.1%) had pre-diabetes on follow-up. About 63 (73.3%) patients had become normoglycemic. Eight (80%) out of the ten patients with new-onset diabetes were on treatment, with five (50%) achieving the target glycemic levels. The associations of new-onset diabetes with age, gender, comorbidities, intensive care stay, and steroid administration were not found to be statistically significant (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      -values 0.809, 0.435, 0.324, 0.402, and 0.289, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation and Conclusions:<\/jats:title>\n                    <jats:p>While a majority of post-COVID patients with diabetic-range hyperglycemia returned to a normoglycemic state after the acute illness had settled down, one in ten developed new-onset diabetes, and an additional one in seven had impaired glucose tolerance. Thus, regular glucose screening is crucial for such patients and lifestyle modifications should be encouraged to reduce the risk of diabetes. Loss to follow-up and reliance on a single set of blood sugar readings for classification were some of the limitations of this study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_140_24","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T02:08:33Z","timestamp":1721959713000},"page":"3374-3380","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Long-term outcome of patients with diabetic-range hyperglycemia first detected during admission for COVID-19: A single-center observational study"],"prefix":"10.4103","volume":"13","author":[{"given":"Ketan","family":"Agarwal","sequence":"first","affiliation":[{"name":"Department of General Medicine, All India Institute of Medical Sciences Patna, Phulwari Sharif, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Kirti","sequence":"additional","affiliation":[{"name":"Department of General Medicine, All India Institute of Medical Sciences Patna, Phulwari Sharif, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyama","family":"Shyama","sequence":"additional","affiliation":[{"name":"Department of General Medicine, All India Institute of Medical Sciences Patna, Phulwari Sharif, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragya","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Community and Family Medicine, All India Institute of Medical Sciences Patna, Phulwari Sharif, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratnadeep","family":"Biswas","sequence":"additional","affiliation":[{"name":"Department of General Medicine, All India Institute of Medical Sciences Patna, Phulwari Sharif, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnu S.","family":"Ojha","sequence":"additional","affiliation":[{"name":"Department of General Medicine, All India Institute of Medical Sciences Patna, Phulwari Sharif, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3389\/fendo.2020.00525","article-title":"Impaired fasting glucose and diabetes are related to higher risks of complications and mortality among patients with coronavirus disease 2019","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Endocrinol"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.dsx.2020.08.034","article-title":"At-admission hyperglycemia is consistently associated with poor prognosis and early intervention can improve outcomes in patients with COVID-19","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"108338","DOI":"10.1016\/j.diabres.2020.108338","article-title":"Hyperglycemia is a strong predictor of poor prognosis in COVID-19","volume":"167","author":"Liu","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes","volume":"47","author":"Yang","year":"2010","journal-title":"Acta Diabetol"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cmet.2020.11.005","article-title":"Expression of SARS-CoV-2 entry factors in the pancreas of normal organ donors and individuals with COVID-19","volume":"32","author":"Kusmartseva","year":"2020","journal-title":"Cell Metab"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s42255-021-00407-6","article-title":"Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection","volume":"3","author":"Montefusco","year":"2021","journal-title":"Nat Metab"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.eprac.2021.04.004","article-title":"COVID-19 may increase the risk of insulin resistance in adult patients without diabetes: A 6-month prospective study","volume":"27","author":"Chen","year":"2021","journal-title":"Endocr Pract"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.immuni.2018.05.005","article-title":"Virus-induced interferon- causes insulin resistance in skeletal muscle and derails glycemic control in obesity","volume":"49","author":"\u0160estan","year":"2018","journal-title":"Immunity"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4239\/wjd.v6.i8.1073","article-title":"Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative review","volume":"6","author":"Tamez-P\u00e9rez","year":"2015","journal-title":"World J Diabetes"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/dmrr.2486","article-title":"Steroid-induced diabetes: A clinical and molecular approach to understanding and treatment","volume":"30","author":"Hwang","year":"2014","journal-title":"Diabetes Metab Res Rev"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4158\/EP09373.OR","article-title":"Effect of dexamethasone on oral glucose tolerance in healthy adults","volume":"16","author":"Abdelmannan","year":"2010","journal-title":"Endocr Pract"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s00134-004-2167-y","article-title":"Stress-hyperglycemia, insulin and immunomodulation in sepsis","volume":"30","author":"Marik","year":"2004","journal-title":"Intensive Care Med"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.2337\/dc21-1318","article-title":"COVID-19, hyperglycemia, and new-onset diabetes","volume":"44","author":"Khunti","year":"2021","journal-title":"Diabetes Care"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S2213-8587(22)00044-4","article-title":"Risks and burdens of incident diabetes in long COVID: A cohort study","volume":"10","author":"Xie","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12916-022-02656-y","article-title":"Risk for newly diagnosed diabetes after COVID-19: A systematic review and meta-analysis","volume":"20","author":"Zhang","year":"2022","journal-title":"BMC Med"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"1170156","DOI":"10.3389\/fpubh.2023.1170156","article-title":"Increased risk of new-onset diabetes in patients with COVID-19: A systematic review and meta-analysis","volume":"11","author":"Li","year":"2023","journal-title":"Front Public Health"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.cmet.2021.05.013","article-title":"SARS-CoV-2 infects human pancreatic cells and elicits cell impairment","volume":"33","author":"Wu","year":"2021","journal-title":"Cell Metab"},{"key":"R22-20240828","first-page":"634","article-title":"Stress-induced hyperglycemia","volume":"79","author":"Mifsud","year":"2018","journal-title":"Br J Hosp Med Lond Engl 2005"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12013-007-0026-5","article-title":"Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes","volume":"48","author":"Robertson","year":"2007","journal-title":"Cell Biochem Biophys"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"649525","DOI":"10.3389\/fendo.2021.649525","article-title":"COVID-19 and diabetes: Understanding the Interrelationship and risks for a severe course","volume":"12","author":"Landstra","year":"2021","journal-title":"Front Endocrinol"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: An overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb","year":"2022","journal-title":"Virol J"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_140_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:58:35Z","timestamp":1787839115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_140_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_140_24","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,26]]},"assertion":[{"value":"2024-01-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}